Perry's The Chemotherapy Source Book, 5ed. [Perry - LIPPINCOTT Williams and Wilkins]
- ISBN/EAN
- 9781451101454
- Editore
- LIPPINCOTT Williams and Wilkins
- Formato
- Brossura
- Anno
- 2012
- Edizione
- 5
- Pagine
- 848
Disponibile
86,00 €
Perry’s The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practice of chemotherapy, and is meant to serve as a “one-stop shop” for information on choice of chemotherapeutic agents, treatment outlines, grading of side effects, and dose modification.
Maggiori Informazioni
| Autore | Perry Michael C. |
|---|---|
| Editore | LIPPINCOTT Williams and Wilkins |
| Anno | 2012 |
| Tipologia | Libro |
| Lingua | Inglese |
| Indice | Section I: Scientific Principles of Chemotherapy 1. Scientific Basis of Cancer Chemotherapy Michael C. Perry and Carl E. Freter 2. Norton–Simon Hypothesis Patrick G. Morris, Teresa A. Gilewski, and Larry Norton 3. Drug Resistance Carl E. Freter and James H. Goldie 4. Principles of Chemotherapy Carl E. Freter 5. Clinical Trials Jeanette A. Linebaugh 6. Hematopoietic Growth Factors Jeffrey Crawford and Susan Blackwell 7. Biologic Response Modifiers: Principles of Biotherapy Mohamad A. Cherry and Howard Ozer Section II: Routes of Administration 8. Intraventricular and Intrathecal Therapy Morris D. Groves, Arthur D. Forman, and Victor A. Levin 9. Intraperitoneal Chemotherapy Maurie Markman 10. Intraarterial Chemotherapy William D. Ensminger 11. Hematopoietic Stem Cell Transplantation Steven Z. Pavletic and James O. Armitage Section III: Management of Drug Toxicity 12. Oral Toxicity Michael T. Brennan, Rajesh V. Lalla, Mark M. Schubert, and Douglas E. Peterson 13. Dermatologic Toxicity Susan K. Ailor and Stacia C. Miles 14. Extravasation Taher Abu Hejleh and Gerald H. Clamon 15. Hypersensitivity Reactions C. Daniel Kingsley 16. Ocular Side Effects of Cancer Therapeutics Ravi K. Bobba and Mark Klein 17. Cardiotoxicity of Cancer Therapy Justin D. Floyd and Michael C. Perry 18. Pulmonary Toxicity of Chemotherapeutic Agents Vamsi P. Guntur and Rajiv Dhand 19. Gastrointestinal Complications of Chemotherapy Rashmi Ramasubbaiah 20. Hepatotoxicity of Chemotherapeutic Agents Ravi K. Bobba, Stephen C. Medlin, and Michael C. Perry 21. Chemotherapy-Induced Renal and Electrolyte Dysfunction Harbaksh Sangha and Ramesh Khanna 22. Chemotherapy-Induced Peripheral Neuropathy Frederick H. Hausheer and Stacey H. Bain 23. Vascular Toxicity of Antineoplastic Agents Ravi K. Bobba and Donald C. Doll 24. Second Malignancies after Chemotherapy Daniel J. Becker, Thomas S. Uldrick, and Alfred I. Neugut 25. Chemotherapy in Pregnancy Monique A. Hartley and Donald C. Doll 26. Gonadal Complications and Teratogenicity of Cancer Therapy Catherine E. Klein and Sonia Okuyama Section IV: Drug Administration 27. Central Venous Access for Chemotherapy Michael B. Nicholl and Paul S. Dale Section V: Current Therapy of Specific Solid Tumors 28. Systemic Therapy for Advanced Melanoma Clay M. Anderson and Rolando D. Breier 29. Chemotherapy of Primary Brain Tumors Lynn S. Ashby and Roy A. Patchell 30. Chemotherapy for Head and Neck Cancer Nicholas W. Choong and Everett E. Vokes 31. Chemotherapy of Lung Cancer Saiama N. Waqar, Janakiraman Subramanian, Daniel Morgensztern, Kumar Rajagopalan, and Ramaswamy Govindan 32. Breast Cancer Carl G. Kardinal, Ravi K. Bobba, and John T. Cole 33. Gastrointestinal Cancer Shadi Haddadin and Chris Papageorgio 34. Endocrine Tumors Steven M. Duffy, Keith Goldstein, and Stephen L. Graziano 35. Chemotherapy of Genitourinary Cancer Maha H. Hussain and Gary R. MacVicar 36. Chemotherapy of Gynecologic Cancers Mark Hunter 37. Chemotherapy of Carcinoma of Unknown Primary Site John D. Hainsworth and F. Anthony Greco 38. Chemotherapy of Bone and Soft Tissue Sarcomas Rashmi Chugh and Scott M. Schuetze 39. Chemotherapy for Pediatric Solid Tumors Barbara A. Gruner Section VI: Chemotherapy of Hematologic Malignancies 40. Chemotherapy for Childhood Leukemia Barbara A. Gruner 41. Chemotherapy of Hodgkin Lymphoma Anne Hudson Blaes and Bruce A. Peterson 42. Non-Hodgkin Lymphoma Philip J. Bierman and James O. Armitage 43. Chronic Lymphocytic Leukemia Preetesh Jain and Kanti R. Rai 44. Acute Myeloid Leukemia Radwan F. Khozouz and Carl E. Freter 45. Myelodysplastic Syndromes Christopher R. Cogle, Rami S. Komrokji, and Alan F. List 46. Management of Myeloproliferative Disorders and Chronic Myeloid Leukemia Ayalew Tefferi 47. Chemotherapy of Multiple Myeloma Robert A. Kyle, S. Vincent Rajkumar, and Francis Buadi Section VII: Appendices I. Chemotherapeutic Agents Shadi Haddadin and Michael C. Perry II. Chemotherapy Programs Shadi Haddadin and Michael C. Perry III. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Michael C. Perry Index |
Questo libro è anche in: